Related Experiment Video
Updated: May 18, 2026
07:59
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Refractory angina pectoris: lessons from the past and current perspectives.
Manolis Vavuranakis1, Maria Kariori, Konstantinos Kalogeras
11st Dept. of Cardiology, Hippokration Hospital, Medical School, National & Kapodistrian University of Athens, 114 V.Sofia Ave, 115 28, Greece. vavouran@otenet.gr
Current Pharmaceutical Design
|September 29, 2012
Summary
Refractory angina, a severe heart condition, often resists standard treatments. Gene therapy offers a promising new approach to improve quality of life and reduce symptoms through angiogenesis.
Area of Science:
- Cardiology
- Vascular Biology
- Regenerative Medicine
Background:
- Refractory angina pectoris is a severe manifestation of ischemic heart disease.
- It is inadequately managed by conventional medications and percutaneous coronary angioplasty (PTCA).
- New therapeutic strategies focus on angiogenesis to improve patient outcomes.
Purpose of the Study:
- To review the definition and pathophysiology of refractory angina.
- To explore angiogenesis and neovascularization imaging techniques.
- To evaluate current and novel treatment options, including gene therapy, for refractory angina.
Main Methods:
- Literature review of refractory angina.
- Analysis of angiogenesis pathophysiology.
- Assessment of imaging techniques for neovascularization.
- Review of clinical trials on angiogenic therapies.
Main Results:
- Gene therapy presents a promising alternative for refractory angina.
- Angiogenic strategies aim to improve functional class and health-related quality of life (HRQOL).
- Clinical trials are evaluated for effectiveness in reducing angina recurrence and improving HRQOL.
Conclusions:
- Gene therapy is a potential breakthrough for refractory angina.
- Improving angiogenesis is key to managing severe ischemic heart disease.
- Further research and clinical trials are essential to validate these novel treatments.
More Related Videos
Related Concept Videos
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
01:30Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
01:29Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...